Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients

Tony Walls1, A G Shankar, Delane Shingadia

  • 1Academic Department of Child Health, Royal London Hospital, Whitechapel, London, UK. t.m.walls@qmul.ac.uk

Insights

Adenovirus is a significant pathogen in children undergoing bone marrow transplantation, causing severe illness. Early detection and antiviral therapy are crucial for reducing mortality in these high-risk pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Hematology/Oncology

Background:

  • Adenovirus is a growing concern in pediatric bone marrow transplant recipients.
  • It causes severe disease in immunocompromised children, with high mortality rates for disseminated infections (up to 60%).
  • Immune responses, particularly T-cell responses, are vital for recovery but not fully understood.

Purpose of the Study:

  • To highlight the increasing recognition of adenovirus as a significant pathogen in pediatric bone marrow transplantation.
  • To emphasize the need for early detection and effective treatment strategies.
  • To discuss the potential impact of new diagnostic and therapeutic approaches.

Main Methods:

  • Review of current understanding of adenovirus infections in immunocompromised children.
  • Discussion of diagnostic advancements, including molecular techniques for early detection.
  • Overview of treatment challenges and potential therapeutic strategies.

Main Results:

  • Adenovirus infections commonly affect the gastrointestinal and urinary tracts.
  • Disseminated infections carry a high mortality rate.
  • Current treatments for immunocompromised patients have shown limited success.

Conclusions:

  • Early detection of adenovirus through molecular diagnostics is now possible, often before symptom onset.
  • Screening allows for prompt treatment initiation.
  • Combined early detection and effective antiviral therapy offer hope for reducing deaths in high-risk children.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...